As more companies are selling nutrition and health-testing services, a WSJ reporter decided to try one. Things got weird. https://t.co/aU4EPFGpP8 ...

西安高压电器研究院股份有限公司 会议资料 证券代码：688334 证券简称：西高院 目 录 议案一：关于变更部分募投项目实施主体、实施地点的议案 ……6 议案二：关于增加公司营业范围、修订《公司章程》并授权办理 工商变更登记的议案………………………………………………………13 西安高压电器研究院股份有限公司 2025 年第二次临时股东大会 西安高压电器研究院股份有限公司 为维护广大投资者的合法权益，保障西安高压电器研究院股份有限 公司（以下简称"公司"）股东在本次股东大会期间依法行使权利，根据 《中华人民共和国公司法》《上市公司股东会规则》《西安高压电器研 究院股份有限公司章程》和公司《股东大会议事规则》等有关规定，特 制定本会议须知： 一、公司负责本次股东大会的议程安排和会务工作,为确认出席大会 的股东或其代理人或其他出席者的出席资格，会议工作人员将对出席会 议者的身份进行必要的核对工作，请被核对者给予配合。 二、出席会议的股东及股东代理人须在会议召开前半小时到会议现 场办理签到手续，自然人股东亲自出席会议的，应持本人身份证原件、 股票账户卡原件等持股证明办理登记；自然人股东委托代理人出席会议 的，代理人应 ...

SAN DIEGO, June 25, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that Rajesh “Raj” Asarpota has been appointed Executive Vice President (EVP) and Chief Financial Officer (CFO), effective June 30, 2025. He will succeed Kevin Herde, who is transitioning to an advisory role on the same date to support an effective transition. “We thank Kevin for his commitment to Marav ...

PRESS RELEASE Neuilly-sur-Seine, France – June 19, 2025 Combined Shareholders’ Meeting of June 19, 2025:All submitted resolutions were adopted The Combined Shareholders’ Meeting of Bureau Veritas (the "Company"), chaired by Mr. Laurent Mignon, Chairman of the Board of directors, was held today at the Company’s head office. All resolutions submitted to the Shareholders’ Meeting were adopted at a large majority, including: The approval of the statutory and consolidated financial statements for the financial ...

PRESS RELEASE Paris – June 18, 2025 Bureau Veritas accelerates its LEAP | 28 strategy execution and evolves its Executive Committee Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC) is accelerating the execution of its LEAP | 28 strategy to reach its vision of being the preferred partner for its customers’ excellence and sustainability. Taking LEAP | 28 to the next level, Bureau Veritas is evolving the structure of its executive committee to drive greater organization ...

The Medical Services sector is experiencing significant transformation fueled by advancements in technology, increased adoption of value-based care and focus on patient-centric solutions and precision medicine. Rising demand for remote treatment is accelerating digital healthcare growth, especially in telemedicine and AI-powered analytics. Providers are using these tools to improve diagnostics, streamline operations, and enhance outcomes, while value-based models promote preventive and personalized care.Acc ...

SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the appointment of Bernd Brust as Chief Executive Officer (CEO) and a member of the Board of Directors, effective immediately. Mr. Brust succeeds William “Trey” Martin III in these roles. “This leadership transition reflects Maravai’s commitment to accelerating innovation, execution, and financial perfo ...

Sotera Health Company (SHC) 2025 Conference June 04, 2025 07:35 AM ET Speaker0 We're, ready to get started. Hi. Good morning. I'm Dave Windley. I cover pharma services, cover a variety of health care areas, but appreciate your being here. Welcome to Jefferies Healthcare Conference for 2025 here in New York. It's a wonderful day on the walkover. I managed to only walk through one weed cloud on my way through, so I think I'm I think I'm still sober. We're pleased to I don't think I've been in the lead off spo ...

Company Overview - Fulgent Genetics, Inc. is a biotechnology company that specializes in diagnostic and genetic laboratory testing services and develops pharmaceutical treatments for various diseases and medical conditions [3] Allegations and Investigations - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving Fulgent, stemming from allegations of providing potentially misleading business information to investors [1] - On February 28, 2025, Fulgent disclosed in its annual report that it received a civil investigative demand from the U.S. Department of Justice related to potential false claims submitted under the federal COVID-19 testing program for uninsured individuals [4] Market Reaction - Following the disclosure of the civil investigative demand, Fulgent's stock price declined by $0.41 per share, or approximately 2.61%, closing at $15.28 per share on March 3, 2025 [5]

PRESS RELEASE Neuilly-sur-Seine, France – May 28, 2025 Availability of preparatory documents for Bureau Veritas’ Combined Shareholders’ Meeting of June 19, 2025 Bureau Veritas’ Combined Shareholders’ Meeting will be held on Thursday, June 19, 2025, at 3:00 p.m., in the Auditorium of the Company’s registered office located at Immeuble Newtime, 40/52, boulevard du Parc in Neuilly-sur-Seine (92200), France, for the purpose of discussing the agenda and the draft resolutions contained in the preliminary Notice ...